These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17341565)

  • 21. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.
    Heikkinen J; Vaheri R; Kainulainen P; Timonen U
    Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of p53 in the endometrial gland in postmenopausal women.
    Koi C; Hachisuga T; Murakami M; Kurita T; Nguyen TT; Shimajiri S; Fujino Y
    Menopause; 2015 Jan; 22(1):104-7. PubMed ID: 24893067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P; Skoog L; Söderqvist G
    Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals.
    Perrone AM; Cerpolini S; Maria Salfi NC; Ceccarelli C; De Giorgi LB; Formelli G; Casadio P; Ghi T; Pelusi G; Pelusi C; Meriggiola MC
    J Sex Med; 2009 Nov; 6(11):3193-200. PubMed ID: 19570144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic findings in women with postmenopausal bleeding: implication for endometrial thickness and circulating levels of sex steroid hormones.
    Yildirim M; Bozkurt N; Kurdoglu M; Taskiran C; Oktem M; Dilek KU
    Arch Gynecol Obstet; 2007 Oct; 276(4):305-10. PubMed ID: 17410372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
    Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
    Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem/stromal cells in post-menopausal endometrium.
    Ulrich D; Tan KS; Deane J; Schwab K; Cheong A; Rosamilia A; Gargett CE
    Hum Reprod; 2014 Sep; 29(9):1895-905. PubMed ID: 24964924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometrial cytology in normal postmenopausal women and during hormone replacement therapy].
    Wei Y; Xue J; Lin S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):432-5. PubMed ID: 9639733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
    Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women.
    Nikander E; Rutanen EM; Nieminen P; Wahlström T; Ylikorkala O; Tiitinen A
    Fertil Steril; 2005 Jan; 83(1):137-42. PubMed ID: 15652899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model.
    Slayden OD; Zelinski MB; Chwalisz K; Hess-Stumpp H; Brenner RM
    Hum Reprod; 2006 Dec; 21(12):3081-90. PubMed ID: 16936297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endometrial growth in continuous, estrogen substitution monotherapy with Estraderm TTS (0.05 mg/die) in 31 postmenopausal females].
    Meuwissen JH; van Langen H; Nielen M
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):351-4. PubMed ID: 1634098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.